Catalyst Pharmaceuticals Inc (CPRX) Insider Trading
- $5,728,674.40
- $44,883,708.95
- Dec. 10, 2024
- Patrick J Mcenany
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 20, 2021 | CEO | 54,161 | $5.52 | Sell | $298,968.72 | |
Aug. 17, 2021 | CFO | 100,000 | $5.67 | Sell | $567,000.00 | |
Dec. 22, 2020 | Insider | 3,668 | $3.45 | Sell | $12,654.60 | |
Sept. 30, 2020 | Director | 7,000 | $2.99 | Buy | $20,930.00 | |
Sept. 30, 2020 | CEO | 15,000 | $2.97 | Buy | $44,550.00 | |
Dec. 5, 2019 | Insider | 150,000 | $4.82 | Sell | $723,000.00 | |
Nov. 27, 2019 | Insider | 100,000 | $4.66 | Sell | $466,000.00 | |
Nov. 21, 2019 | Insider | 100,000 | $4.50 | Sell | $450,000.00 | |
Oct. 11, 2019 | Director | 10,000 | $4.70 | Buy | $47,000.00 | |
Oct. 3, 2019 | CEO | 10,000 | $4.89 | Buy | $48,900.00 | |
June 11, 2019 | CEO | 25,000 | $3.23 | Buy | $80,750.00 | |
Dec. 27, 2018 | Director | 25,000 | $1.91 | Buy | $47,750.00 | |
Dec. 19, 2018 | Insider | 20,000 | $2.24 | Buy | $44,800.00 | |
Dec. 14, 2018 | Director | 20,000 | $2.50 | Buy | $50,000.00 | |
June 7, 2018 | Director | 4,000 | $3.31 | Buy | $13,240.00 | |
June 1, 2018 | Director | 5,000 | $3.74 | Buy | $18,700.00 | |
May 30, 2018 | Director | 20,000 | $3.75 | Buy | $75,000.00 | |
April 3, 2018 | Insider | 20,000 | $2.29 | Buy | $45,800.00 | |
Sept. 5, 2017 | Insider | 20,000 | $2.58 | Buy | $51,600.00 | |
July 12, 2016 | Director | 20,000 | $0.81 | Buy | $16,200.00 | |
June 17, 2016 | Director | 15,000 | $0.76 | Buy | $11,400.00 | |
June 14, 2016 | Director | 50,000 | $0.65 | Buy | $32,500.00 | |
June 14, 2016 | CEO | 105,300 | $0.65 | Buy | $68,445.00 | |
April 26, 2016 | CEO | 50,000 | $0.65 | Buy | $32,500.00 | |
April 26, 2016 | Director | 20,000 | $0.60 | Buy | $12,000.00 | |
March 17, 2016 | Director | 10,000 | $1.06 | Buy | $10,600.00 | |
March 16, 2016 | Director | 10,000 | $1.11 | Buy | $11,100.00 | |
Jan. 11, 2016 | COO | 7,933 | $1.80 | Buy | $14,279.40 | |
Jan. 8, 2016 | Director | 5,000 | $1.94 | Buy | $9,700.00 | |
Jan. 7, 2016 | Director | 25,000 | $2.03 | Buy | $50,750.00 | |
Dec. 28, 2015 | CEO | 25,000 | $2.39 | Buy | $59,750.00 | |
Dec. 23, 2015 | Director | 5,000 | $2.41 | Buy | $12,050.00 | |
Nov. 19, 2015 | Director | 5,000 | $2.30 | Buy | $11,500.00 | |
Oct. 23, 2015 | VP | 22,800 | $3.34 | Sell | $76,152.00 | |
Oct. 1, 2015 | CEO | 10,000 | $2.81 | Buy | $28,100.00 | |
May 1, 2015 | EVP | 1,700 | $3.20 | Buy | $5,440.00 | |
April 30, 2015 | Director | 10,000 | $3.29 | Buy | $32,900.00 | |
April 28, 2015 | EVP | 2,000 | $3.55 | Buy | $7,100.00 | |
April 27, 2015 | Director | 15,000 | $3.71 | Buy | $55,650.00 | |
April 27, 2015 | CEO | 5,000 | $3.79 | Buy | $18,950.00 | |
April 24, 2015 | Director | 5,000 | $3.80 | Buy | $19,000.00 | |
March 27, 2015 | Director | 5,000 | $4.17 | Buy | $20,850.00 | |
Jan. 20, 2015 | EVP | 21,000 | $2.96 | Buy | $62,160.00 | |
Jan. 13, 2015 | Director | 10,000 | $3.00 | Buy | $30,000.00 | |
Jan. 8, 2015 | CEO | 50,000 | $2.80 | Buy | $140,000.00 | |
Oct. 3, 2014 | VP | 10,000 | $2.65 | Buy | $26,500.00 | |
June 4, 2014 | COO | 100,000 | $2.17 | Buy | $217,000.00 | |
May 21, 2014 | CEO | 25,000 | $1.89 | Buy | $47,250.00 | |
May 19, 2014 | Director | 10,000 | $1.83 | Buy | $18,300.00 | |
April 16, 2014 | Director | 5,000 | $2.02 | Buy | $10,100.00 |
Insiders are both buying and selling Catalyst Pharmaceuticals Inc stock.
The insider traders at Catalyst Pharmaceuticals Inc are: Patrick J Mcenany, Charles B O'keeffe, Alicia Grande, Steve Miller, Gary Ingenito, Donald A Denkhaus, David S Tierney, Philip H Coelho, David D Muth, Charles O'keeffe, Carmen Jeffrey Del, Molly Harper, Brian Elsbernd, Patrick Mcenany, Preethi Sundaram, Biomarin Pharmaceutical Inc, Richard J Daly, and M Douglas Winship
The most active insider trader at Catalyst Pharmaceuticals Inc is Patrick J Mcenany with 22 trades.
Alicia Grande has sold the most Catalyst Pharmaceuticals Inc stock with a total value of $12,860,266.90.
Biomarin Pharmaceutical Inc has bought the most Catalyst Pharmaceuticals Inc stock with a total value of $7,500,000.00.
The most recent insider trade for Catalyst Pharmaceuticals Inc was on Dec. 10, 2024.
The single biggest insider buy for Catalyst Pharmaceuticals Inc was from Biomarin Pharmaceutical Inc with a total value of $3,750,000.00 on Dec. 8, 2012.
The single biggest insider sell for Catalyst Pharmaceuticals Inc was from Patrick J Mcenany with a total value of $5,467,000.00 on Nov. 18, 2022.